First line of defence (C-70311)

28 February 2019
Winter 2019

Madeleine Bailey looks at the cutting-edge research that may one day lead to a diagnostic eye test for Alzheimer’s disease.

Dementia is “the most feared health condition of our time”, says Chief Executive of Alzheimer’s Society Jeremy Hughes. Few who have been touched by it will disagree. Symptoms common to this condition include a decline in memory, cognitive abilities, use of language and visual perception, along with changes to mood and sometimes personality. 

Alzheimer’s disease (AD) is responsible for 62 per cent of dementia cases (Alzheimer’s Society, 2018a). It currently affects more than 520,000 people in the UK and overall dementia rates are predicted to more than double by 2050 (Alzheimer’s Society, 2018b), but an effective treatment remains elusive.

Sign in to continue

Forgotten password?
Register

Not already a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

PhD studentship available in collaboration with the Eye Hospital and the Greater Manchester Mental Health NHS Foundation Trust.

We have responded to a green paper on prevention public from the Department of Health and Social Care.

This live webinar by Dr Rakhee Shah and Mr Simon Raw provides up-to-date guidance and research for adapting an eye examination to suit the needs of a patient with dementia.